Q
QuantAbundance

Notícias

Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

30,897 signal articles · 0 in last 24h · 157,635 total before filter · latest 1d ago
0last 24h
732last 7d
118● bullish (7d)
71● bearish (7d)
214publishers
AllMacro172Earnings127M&A79Regulatory15Product14Analyst19
✕ clear all filterssentiment: neutralSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
Why Is Merck (MRK) In Focus After Japan Cleared A New Dosing Option?
Simply Wall St.7d agoneutral
Why Is Merck (MRK) In Focus After Japan Cleared A New Dosing Option?

Merck (NYSE:MRK) received Japanese approval for KEYTRUDA QLEX (KEYJECT), its first subcutaneous KEYTRUDA formulation, for all existing local indications. The new subcutaneous version offers an alternative to intravenous dosing, aimed at faster administration for patients and clinicians. This approval broadens Merck's oncology treatment options in Japan, a key international market for its immunotherapy portfolio. The KEYTRUDA QLEX subcutaneous green light in Japan matters. However, investors...

NuScale Power (SMR) Draws Fresh Attention, Is The Stock Still A Bargain?
Simply Wall St.7d agoneutral
NuScale Power (SMR) Draws Fresh Attention, Is The Stock Still A Bargain?

Why NuScale Power Is Back in the Spotlight NuScale Power (SMR) is drawing fresh attention as investors reassess nuclear backed grid capacity for energy hungry AI data centers, with the stock trading near US$8.79 as of 21 September 2026. The business has advanced regulatory and engineering work, including projects in Romania and ongoing talks with the Tennessee Valley Authority. Its current backlog remains largely non binding, and first reactor deployments are not expected until the early...

Jim Cramer Praises OKTA for Tackling AI Security Threats
Insider Monkey7d agoneutral
Jim Cramer Praises OKTA for Tackling AI Security Threats

During the September 18 episode of CNBC’s Mad Money, Jim Cramer highlighted Okta, Inc. (NASDAQ:OKTA) after speaking with technology leaders in Silicon Valley. He stated: Let’s start with the most consequential. On Wednesday, we have an Okta analyst, okay? This is it. Of all the companies I had on the show this past week in […]

3 Consumer Stocks We Steer Clear Of
StockStory7d agoneutral
3 Consumer Stocks We Steer Clear Of

Consumer discretionary businesses are levered to the highs and lows of economic cycles. Over the past six months, it seems like demand may be facing some headwinds as the industry’s 1.8% return has lagged the S&P 500 by 14.5 percentage points.

This Power Parts Maker’s Stock Has Gained 316% in 2026. It’s Rising Again Today on Boost to Growth Guidance.
Barrons.com7d agoneutral
This Power Parts Maker’s Stock Has Gained 316% in 2026. It’s Rising Again Today on Boost to Growth Guidance.

Power electronics company Vicor jumped Tuesday after nearly doubling its sequential revenue growth guidance, driven by royalty fees from a new patent license deal for its artificial-intelligence-power technology. Vicor raised its sequential revenue growth forecast for the fiscal third quarter to more than 20%, up from its previous 10% projection, the company said in press release. Vinciarelli added that the clients approached Vicor after realizing that using unlicensed power delivery components put their AI computing systems at risk of import bans from the U.S. International Trade Commission and patent infringement litigation.

Pfizer Refocuses Growth Strategy as New Products Offset COVID Decline
MarketBeat7d agoneutral
Pfizer Refocuses Growth Strategy as New Products Offset COVID Decline

Pfizer (NYSE:PFE) has rebuilt its commercial model around newer and acquired products while reducing exposure to its COVID-19 franchise, according to Alexandre de Germay, the company’s chief international commercial officer and executive vice president. Speaking with Chris Schott at a company event

This Warren Buffett Favorite Still Has Room to Run
24/7 Wall St.7d agoneutral
This Warren Buffett Favorite Still Has Room to Run

Warren Buffett has held Coca-Cola since 1988, and after a 35% run over the past year, most investors assume the opportunity has passed. Our model disagrees, and the reason comes down to one number buried inside the latest earnings report.

These are the cybersecurity stocks built for the AI era
Yahoo Finance Video7d agoneutralVIDEO
These are the cybersecurity stocks built for the AI era

Wedbush Securities' vice president of TMT Equity Research, Steven Wahrhaftig, joins Yahoo Finance's Ines Ferré to discuss key cybersecurity stocks, including CrowdStrike (CRWD) and Palo Alto Networks (PANW), that could be worth considering for investors following recent breaches such as the OpenAI-Hugging Face hack.

3 Consumer Stocks We Think Twice About
StockStory7d agoneutral
3 Consumer Stocks We Think Twice About

Regarded as defensive investments, consumer staples stocks are generally safe bets in choppy markets. The flip side is that they frequently fall behind growth industries when times are good, and this was the reality over the past six months as the sector’s flat performance trailed the S&P 500’s 16.2% gain.

Health Care Roundup: Market Talk
The Wall Street Journal7d agoneutral
Health Care Roundup: Market Talk

Find insight on Novo Nordisk, Roche Holding, IHH Healthcare and more in the latest Market Talks covering Health Care.